Norman Law
Co-Founder and Director at MitoRx Therapeutics
Experienced leader in biotech IP, skilled in patent law, technology evaluation and competitive intelligence. Also Head of IP at Adaptimmune ($ADAP). Pharmacologist with 28 years industry experience who has taken two drugs from bench to market at TopoTarget (now Onxeo), research training at Yale and Cornell.
Visit website: https://www.mitorxtherapeutics.com/#Our-team/#norman
See also: 
MitoRx Therapeutics
- Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases
Details last updated 27-Aug-2022
Norman Law is also referenced in the following:
MitoRx Therapeutics
Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases
